• 1
    Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three fold rise in Crohn's disease. Gut 1989; 30: 61822.
  • 2
    Rose JDR, Roberts GM, Williams G, Mayberry JF, Rhodes J. Cardiff Crohn's disease jubilee: the incidence of over 50 years. Gut 1988; 29: 34651.
  • 3
    Armitage E, Drummond H, Ghosh S, Ferguson A. Incidence of juvenile-onset Crohn's disease in Scotland [letter]. Lancet 1999; 353: 14967.
  • 4
    Rutgeerts PJ. Prevention of early recurrence of Crohn's disease after ileal resection with ileocolonic anastomosis. Eur J Gastroenterol Hepatol 1994; 6: 1136.
  • 5
    Binder V, Hendriken C, Kreiner S. Prognosis in Crohn's disease — based on results from a regional patient group from the county of Copenhagen. Gut 1985; 26: 14650.
  • 6
    Munkholm P, Langholz E, Davidsen M, Binder V. Disease activity courses in a regional cohort of Crohn's disease patients. Scand J Gastroenterol 1995; 30: 699706.
  • 7
    Greenberg GR, Feagan BG, Martin F, et al.Oral budesonide as maintenance treatment for Crohn's disease: a placebo controlled dose-ranging study. Gastroenterology 1996; 110: 4551.
  • 8
    Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn's disease index; National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70: 43944.
  • 9
    Hodgson HJF, Bhatti M. Assessment of disease activity in ulcerative colitis and Crohn's disease. Inflammatory Bowel Dis 1995; 1: 11734.
  • 10
    Cellier C, Sahmound T, Froguel E, et al.Correlations between clinical activity, endoscopic severity and biological parameters in colonic or ileocolonic Crohn's disease — a prospective multicentre study of 121 cases. Gut 1994; 35: 2315.
  • 11
    Acciuffi S, Ghosh S, Ferguson A. Strengths and limitations of the Crohn's disease activity index, revealed by an objective gut lavage test of gastrointestinal protein loss. Aliment Pharmacol Ther 1997; 10: 3216.
  • 12
    Saverymuttu SH. Clinical remission in Crohn's disease — assessment using faecal 111-In granulocyte excretion. Digestion 1986; 33: 749.
  • 13
    Saverymuttu SH, Camilleri M, Rees H, Lavender JP, Hodgson HJF, Chadwick VS. Indium 111-granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Gastroenterology 1986; 90: 11218.
  • 14
    Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJF, Chadwick VS. Quantitative faecal Indium 111-labeled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology 1983; 85: 13339.
  • 15
    Roseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999; 34: 504.
  • 16
    Schreiber S, Nikolaus S, Hampe J, et al.Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease. Lancet 1999; 353: 45961.
  • 17
    Tibble J, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 2000; 119: 1522.
  • 18
    Arnott IDR, Drummond H, Ghosh S. Gut mucosal secretion of interleukin 1β and interleukin-8 predicts relapse in clinically inactive Crohn's disease. Dig Dis Sci 2001; 46: 4029.
  • 19
    D'Inca R, Di Leo V, Corrao G, et al.Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol 1999; 94: 295660.
  • 20
    Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 1993; 341: 14379.
  • 21
    Ghosh S, Acciuffi S, Ferguson A. Prognostic value of whole gut lavage fluid analysis in Crohn's disease. Gut 1996; 38(Suppl. 1): F231F231.
  • 22
    Arnott IDR, Kingstone K, Ghosh S. Abnormal intestinal permeability predicts relapse in patients with inactive Crohn's disease. Scand J Gastroenterol 2000; 35: 11639.
  • 23
    Klein O, Houdret N, Desreumaux P, et al.Intestinal permeability is not predictive of endoscopic recurrence in patients operated on for Crohn's disease. Gastroenterology 1997; 112: A1016A1016(Abstract).
  • 24
    Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000; 119: 17404.
  • 25
    Andre C, Descos I, Vignal J, Gillon J. C-reactive protein as a predictor of relapse in asymptomatic patients with Crohn's disease. Scott Med J 1983; 28: 269.
  • 26
    Boirivant M, Leoni M, Taricotti D, Fais S, Squarcia O, Pallone F. The clinical significance of serum C reactive protein levels in Crohn's disease. J Clin Gastroenterol 1988; 10: 4015.
  • 27
    Campbell CA, Walker-Smith JA, Hindocha P, Adinolfi M. Acute phase proteins in chronic inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr 1982; 1: 193200.
  • 28
    Louis E, Belaiche J, Van Kemseke C, et al.A high serum concentration of interleukin-6 is predictive of relapse in quiescent Crohn's disease. Eur J Gastroenterol Hepatol 1997; 9: 93944.
  • 29
    Reinisch W, Gasche C, Tillinger W, et al.Clinical relevance of serum interleukin-6 in Crohn's disease: Single point measurements, therapy monitoring and prediction of clinical relapse. Am J Gastroenterol 1999; 94: 215664.
    Direct Link:
  • 30
    Van Kemseke C, Belaiche J, Louis E. Frequently relapsing Crohn's disease is characterized by persistent elevation in interleukin-6 and soluble interleukin-2 receptor serum levels during remission. Int J Colorectal Dis 2000; 15: 20610.
  • 31
    Louis E, Belaiche J, Van Kemseke C, Schaaf N, Mahieu P, Mary JY. Soluble interleukin-2 receptor in Crohn's disease, assessment of disease activity and prediction of relapse. Dig Dis Sci 1994; 40: 17506.
  • 32
    Arnott IDR, Drummond HE, Ghosh S. Frequency of continuing mucosal inflammation in clinically inactive Crohn's disease. Scott Med J 2001; 46: 1369.
  • 33
    Sachar DB. Predicting relapses in Crohn's disease. Dig Dis Sci 1987; 32: 2068.
  • 34
    Sahmound T, Hoctin-Boes G, Modigliani R, et al.Identifying patients with a high risk of relapse in quiescent Crohn's disease. Gut 1995; 37: 8118.
  • 35
    Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease (NCCDS). Gastroenterology 1979; 77: 898906.
  • 36
    Steinhardt HJ, Loeschke K, Kasper H, Holtermuller KH, Schafer H. European Cooperative Crohn's Disease Study (ECCDS): Clinical features and natural history. Digestion 1985; 31: 97108.
  • 37
    De Domball FT, Burton IL, Clamp SE, Goligher JC. Short-term course and prognosis of Crohn's disease. Gut 1974; 15: 43543.
  • 38
    Pinchbeck BR, Imes S, Dinwoodie A, Thompson ABR. Discriminant function analysis to calculate a Crohn's activity group scale to predict future inactive or active disease. J Clin Gastroenterol 1988; 10: 498504.
  • 39
    Brignola C, Campieri M, Bazzocchi G, Farruggia P, Tragnone A, Lanfranchi GA. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology 1986; 91: 14904.
  • 40
    Farmer RG, Whelan G, Fazio VW. Long term follow up of patients with Crohn's disease. Relationship between clinical pattern and prognosis. Gastroenterology 1985; 88: 181825.
  • 41
    Wright JP. Factors influencing first relapse in patients with Crohn's disease. J Clin Gastroenterol 1992; 15: 126.
  • 42
    Siproudhis L, Mortaji A, Mary JY, Juguet F, Bretagne JF, Gosselin M. Anal lesions: any significant prognosis in Crohn's disease? Eur J Gastroenterol Hepatol 1997; 9: 23943.
  • 43
    Cottone M, Rosselli M, Orlando A, et al.Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 6438.
  • 44
    Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98: 11238.
  • 45
    Yamamoto T, Allan RN, Keighley MR. Smoking is a predictive factor for outcome after colectomy and ileorectal anastomosis in patients with Crohn's colitis. Br J Surg 1999; 86: 106970.DOI: 10.1046/j.1365-2168.1999.01189.x
  • 46
    Russel MG, Nieman FH, Bergers JM, Stockbrugger RW. Cigarette smoking and quality of life in patients with inflammatory bowel disease. South Limburg IBD Study Group [see comments]. Eur J Gastroenterol Hepatol 1996; 8: 107581.
  • 47
    Palli D, Trallori G, Saieva C, et al.General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut 1998; 42: 1759.
  • 48
    Cosnes J, Carbonnel F, Beaugerie L, Le Quintrec Y, Gendre JP. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110: 42431.
  • 49
    Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 1998; 114: 114350.
  • 50
    Bouhnik Y, Lemann M, Mary JY, et al.Long term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 2159.
  • 51
    Tytgat GNJ, Mulder CJJ, Brummelkamp WH. Endoscopic lesions in Crohn's disease early after ileocaecal resection. Endoscopy 1988; 20: 2602.
  • 52
    Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M. Predictability of the post operative course of Crohn's disease. Gastroenterology 1990; 99: 95663.
  • 53
    Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn's disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 66572.
  • 54
    Olaison G, Smedh K, Sjodahl R. Natural course of Crohn's disease after ileocolonic resection — endoscopically visualized ileal ulcers preceding symptoms. Gut 1992; 33: 3315.
  • 55
    DeJong E, Vandullemen HM, Slors JFM, Dekkers P, Vandeventer SJH, Tytgat GNJ. Correlation between early recurrence and reoperation after ileocolonic resection in Crohn's disease: a prospective study. J Am Coll Surg 1996; 182: 5038.
  • 56
    Lorenz-Myer H, Malchow H, Miller B, Stock H, Brandes JW. European Cooperative Crohn's disease study (ECCDS). Colonosc Dig 1985; 31: 10919.
  • 57
    Gomes P, Du Boulay C, Smith CL, Holdstock G. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut 1986; 27: 925.
  • 58
    Breese EJ, Michie CA, Nicholls SW, et al.Tumour necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 1994; 106: 145566.
  • 59
    Nagel E, Bartels M, Pichlmayr R. Scanning electron microscope lesions in Crohn's disease: Relevance for the interpretation of post operative recurrence. Gastroenterology 1995; 108: 37682.
  • 60
    Heinmann TM, Greenstein AJ, Lewis B, Kaufman D, Heinmann DM, Aufses AHJ. Prediction of early symptomatic recurrence after intestinal resection in Crohn's disease. Ann Surg 1993; 218: 2949.
  • 61
    Heinmann TM, Aufses AHJ. The role of peripheral lymphocytes in the prediction of recurrence in Crohn's disease. Surg Gynecol Obstet 1985; 160: 2958.
  • 62
    Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of paediatric Crohn's disease. J Pediatr Gastroenterol Nutr 1989; 9: 1826.
  • 63
    Borley NR, Mortensen NJ, Jewell DP. Preventing postoperative recurrence of Crohn's disease. Br J Surg 1997; 84: 1493502.
  • 64
    Williams JG, Wong WD, Rothenberger DA, Goldberg SM. Recurrence of Crohn's disease after resection. Br J Surg 1991; 78: 109.
  • 65
    Musso A, Sostegni R, Astegiano M, et al.Smoking and clinical course of Crohn's disease: any adverse effect. Gastroenterology 1995; 108: A882A882(Abstract).
  • 66
    Lock MR, Farmer RG, Fazio VW, Jagelman DG, Lavery IC, Weakley FL. Recurrence and reoperation for Crohn's disease. The role of disease location in prognosis. N Engl J Med 1981; 304: 15868.
  • 67
    Greenstein AJ, Sachar DB, Pasternack BS, Janowitz HD. Reoperation and recurrence in Crohn's colitis and ileocolitis. Crude and cumulative rates. N Engl J Med 1975; 293: 68590.
  • 68
    Whelan G, Farmer RG, Fazio VW, Goormastic M. Recurrence after surgery in Crohn's disease (clinical pattern) and surgical indication. Gastroenterology 1985; 88: 182633.
  • 69
    Binder H, Freeman HJ. Risk factors predicting recurrent small intestinal resection for Crohn's disease of the terminal ileum. Can J Gastroenterol 1994; 8: 1938.
  • 70
    Holzheimer RG, Molloy RG, Wittmann DH. Postoperative complications predict recurrence of Crohn's disease. Eur J Surg 1995; 161: 12935.
  • 71
    Griffiths AM, Wesson DE, Shandling B, Corey M, Sherman PM. Factors influencing postoperative recurrence of Crohn's disease in childhood. Gut 1991; 32: 4915.
  • 72
    Basilisco G, Campanini M, Cesana B, Ranzi T, Bianchi P. Risk factors for first operation in Crohn's disease. Am J Gastroenterol 1997; 84: 74952.
  • 73
    Post S, Herfarth C, Bohm E, et al.The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease. Ann Surg 1996; 223: 25360.
  • 74
    Besnard M, Jaby O, Mougessot JF, et al.Postoperative outcome of Crohn's disease in 30 children. Gut 1998; 43: 6348.
  • 75
    Pallone F, Boirivant M, Stazi MA, Cosintino R, Prantera C, Torsoli A. Analysis of clinical course of postoperative recurrence in Crohn's disease of distal ileum. Dig Dis Sci 1992; 37: 2159.
  • 76
    Present DH, Meltzer SJ, Krumholz MP, et al.6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med 1989; 111: 6419.